Imperial College AHSC is governed jointly by the partner organisations and serviced by the AHSC Directorate.

An overview of Imperial College AHSC governance arrangements is shown below; and these are formalised through a Joint Working Agreement, which sets out the mechanisms and structures for how the partners work together, including the ownership and exploitation of intellectual property.

Strategic Partnership Board

The Strategic Partnership Board (SPB) is the responsible body for monitoring the AHSC’s progress. It includes Board level representatives from the NHS Partner Trusts and Imperial, providing a direct line to the leadership of each partner organisation.

Strategic Partnership Board membership

Chair

Professor Sir Mark Walport (independent)

Imperial College London

Professor Alice Gast– President of Imperial College London

Professor Ian Walmsley – Provost of Imperial College London

Imperial College Healthcare NHS Trust

Professor Tim Orchard – Chief Executive of Imperial College Healthcare NHS Trust

Mr Bob Alexander – Interim Chair of Imperial College Healthcare NHS Trust

The Royal Marsden NHS Foundation Trust

Ms Cally Palmer CBE – Chief Executive of The Royal Marsden NHS Foundation Trust

Mr Charles Alexander – Chairman of The Royal Marsden Hospital NHS Foundation Trust

The Institute of Cancer Research (ICR)

Professor Paul Workman – Chief Executive and President of The Institute of Cancer Research (ICR)

Mr Luke Johnson – Chairman of The Institute of Cancer Research (ICR)

Chelsea & Westminster NHS Foundation Trust

Ms Lesley Watts – Chief Executive

Mr Stephen Gill – Interim Chair

Imperial College Academic Health Science Centre

Professor Jonathan Weber – Director of Imperial College AHSC,  Dean of the Faculty of Medicine at Imperial College London and Jeferriss Professor of Communicable Diseases and GU Medicine

 

Joint Executive Group

The Joint Executive Group (JEG) is the body directly responsible for successfully implementing Imperial College AHSC’s strategy and managing the delivery of its work programme. The Group is chaired by Professor Jonathan Weber, Director of Imperial College AHSC.

Imperial College AHSC governance arrangements are formalised through a Joint Working Agreement.  This sets out the parameters, mechanisms and structures for how the partners work together, including the ownership and exploitation of intellectual property.

JEG members are senior leaders of the partner organisations

Professor Jonathan Weber, FMedSci, FRCP – Director of Imperial College AHSC,  Dean of the Faculty of Medicine at Imperial College London and Jeferriss Professor of Communicable Diseases and GU Medicine

Mr Martin Lupton – Vice Dean (Education) of the Faculty of Medicine, Imperial College London

Dr Chris Watkins, Faculty Operating Officer of the Faculty of Medicine, Imperial College London

Professor Martin Wilkins – Vice Dean (Research) of the Faculty of Medicine, Imperial College London

Professor Timothy Orchard – Chief Executive of Imperial College Healthcare NHS Trust

Professor Julian Redhead – Medical Director of Imperial College Healthcare NHS Trust

Professor Bob Klaber– Director of Strategy, Research and Innovation, Imperial College Healthcare NHS Trust

Ms Cally Palmer CBE – Chief Executive of  The Royal Marsden NHS Foundation Trust

Dr Nicholas Van As – Medical Director of  The Royal Marsden NHS Foundation Trust

Karl Munslow-Ong – Chief Operating Officer of The Royal Marsden NHS Foundation Trust

Professor Paul Workman – Chief Executive and President of The Institute of Cancer Research (ICR)

Dr Barbara Pittam – Scientific Secretary, Registrar and Director of Academic Services, The Institute of Cancer Research (ICR)

Professor Kevin HarringtonHead of Division and Team Leader, The Institute of Cancer Research (ICR)

Ms Lesley Watts – Chief Executive, Chelsea & Westminster NHS Foundation Trust

Dr Roger Chinn – Chief Medical Officer, Chelsea & Westminster NHS Foundation Trust

Ms Pippa Nightingale – Chief Nurse, Chelsea & Westminster NHS Foundation Trust

AHSC Directorate

The Joint Executive Group provides direction to the AHSC Directorate, led by Professor Jonathan Weber. The Directorate is responsible for ensuring delivery of the AHSC work programme.

Members of the Directorate

  • Professor Jonathan Weber Director of Imperial College AHSC,  Dean of the Faculty of Medicine at Imperial College London and Jeferriss Professor of Communicable Diseases and GU Medicine
  • Dr Angela Cooper – Director of External Partnerships, Faculty of Medicine, Imperial College London
  • Dr Seema Alexander – AHSC Project Manager, Faculty of Medicine, Imperial College London
  • Elizabeth Hanna- AHSC Project Manager, Faculty of Medicine, Imperial College London
  • Ingrid Temmerman – AHSC Executive Assistant, Faculty of Medicine, Imperial College London

Joint Infrastructure 

Clinical Academic Training Office

  • Professor Jeremy Levy – Director of the Clinical Academic Training Office (CATO), Imperial College London
  • Samantha Hobbs – CATO Manager, Imperial College London

Research

  • Dr Des Walsh – Director of Research Strategy, Faculty of Medicine, Imperial College London
  • Dr Paul Craven – Head of Clinical Research Operations, Faculty of Medicine, Imperial College London
  • Ruth Nicholson – Head, Joint Research Compliance Office (JCRO), Imperial College London
  • Professor Paul Elliott – AHSC Director of Information Governance

Communications

  • Maxine MyersAHSC Communications Manager, Communications and Public Affairs, Imperial College London

For details of how to get in touch with the Directorate, please visit our contact us page.